In addition, circNFIX counters heart hypertrophy by indirectly targeting activating transcription factor 3 (ATF3) in cardiomyocytes through binding to the microRNA miR-145-5p [64]. The gene discussed is ATF3; the disease is cardiac hypertrophy.